Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Supports PDUFA VIII Commitment Letter and…
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…
Learn more
BIO Statement on Senate Reintroduction of the…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
Learn more
BIO International Convention Returns to San Diego…
20,000+ biotech leaders gather with a shared mission: to improve lives  SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Urges Congress to Extend Biofuels Tax Incentives
March 12, 2019
The Biotechnology Innovation Organization BIO today submitted the following statement for the record to the House Ways and Means Subcommittee on Select Revenue Measures urging Congress to retroactively extend the biofuels tax incentives that…
BIO Applauds Trump Administration for Moving Closer to Fulfilling E15 Promise
March 12, 2019
The Biotechnology Innovation Organization (BIO) released the following statement after the U.S. Environmental Protection Agency (EPA) announced its proposed rule allowing for the summertime use of E15 gasoline.
BIO Statement on President’s Proposed 2020 Budget
March 11, 2019
Washington, DC (March 11, 2019) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding President Trump’s FY 2020 budget proposal:
BIO Applauds FDA Action on AquAdvantage® Salmon
March 8, 2019
The Biotechnology Innovation Organization (BIO) released the following statement on the action taken today by the U.S. Food & Drug Administration (FDA) which will allow AquaBounty Technologies, an American company, to commercialize its…
BIO Applauds Multi-Agency Framework for Advancing the Bioeconomy
March 5, 2019
The Biotechnology Innovation Organization (BIO) today released the following statement in response to the release of The Bioeconomy Initiative: Implementation Framework, a multi-agency strategy aimed at accelerating innovative technologies that…
BIO Statement on Ambassador Lighthizer and Secretary Perdue Testimonies
February 27, 2019
BIO President and CEO Jim Greenwood released the following statement on U.S. Trade Representative Robert Lighthizer’s testimony at a House Ways and Means Committee hearing on the U.S.-China trade deal and U.S. Secretary of Agriculture Sonny…
BIO Announces Partnership with Taiwan BIO for 2019 Conference and Exhibition
February 20, 2019
Washington, DC (February 20, 2019) – The Biotechnology Innovation Organization (BIO) announced today it will join the Taiwan Bio-Industry Organization (Taiwan BIO) to host BIO Asia-Taiwan from July 24-28 in Taipei, Taiwan. The event…
BIO Statement on CMS Proposed Decision Memo for the CAR-T National Coverage Determination
February 15, 2019
BIO Executive Vice President for Health Policy Dan Durham issued the following statement regarding the CMS proposed decision memo for the CAR-T National Coverage Determination.
BIO Applauds Sens. Tillis, Sinema, Peters, and Perdue for Introducing the Fostering Innovation Act
February 13, 2019
The Biotechnology Innovation Organization (BIO) applauds Sens. Thom Tillis (R-NC), Kyrsten Sinema (D-AZ), Gary Peters (D-MI), and David Perdue (R-GA) for introducing the Fostering Innovation Act (S.452) to build on the success of the Jumpstart Our…
New Report Demonstrates High Costs and Low Benefits of Sarbanes-Oxley 404(b) Compliance for Emerging Biotechs
February 11, 2019
Washington, DC (February 11, 2019) – Today, to recognize National Inventors’ Day, the Biotechnology Innovation Organization (BIO) released a new report, “Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Emerging Growth…